PropertyValue
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/ns/prov#value
  • However, none of them is a sure thing, as existing drugs from sanofi-aventis (NYSE: SNY ) , Bristol-Myers Squibb (NYSE: BMY ) , and Vertex Pharmaceuticals (Nasdaq: VRTX ) have a leg up on Merck and the rest of the competition.
http://www.w3.org/ns/prov#wasQuotedFrom
  • fool.com